Market Cap 6.03B
Revenue (ttm) 329.00M
Net Income (ttm) 23.38M
EPS (ttm) N/A
PE Ratio 162.17
Forward PE 45.88
Profit Margin 7.11%
Debt to Equity Ratio 1.03
Volume 1,864,700
Avg Vol 2,084,534
Day's Range N/A - N/A
Shares Out 158.76M
Stochastic %K 85%
Beta 1.91
Analysts Strong Sell
Price Target $40.50

Company Profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's de...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 554 4484
Fax: 212 554 4531
Address:
3020 Carrington Mill Blvd., Suite 475, Morrisville, United States
JinxyBio
JinxyBio Jul. 17 at 8:19 AM
$TGTX 2516
0 · Reply
Chartist0_0
Chartist0_0 Jul. 17 at 2:29 AM
$TGTX There's some really dumb ass people on this board. I've blocked and muted a lot of them and will continue to do so.
0 · Reply
Chartist0_0
Chartist0_0 Jul. 17 at 1:08 AM
$TGTX To value the business you can discount the future cash flows. This requires some estimation of what those cash flows will be. Go out to when the patent expires. Discount those flows to the present using some discount rate. I'd say 6% would work. I am surprised the company hasn't been bought out already. To me, this means MW wants too much, or it would be a done deal by now.
3 · Reply
Looey
Looey Jul. 17 at 12:51 AM
$TGTX Seagen was acquired by Pfizer for approximately $43 billion in a deal announced in March 2023 and completed in December 2023, at $229 per share in cash. Celgene was acquired by Bristol-Myers Squibb for approximately $74 billion in a cash and stock deal announced in January 2019 and completed in November 2019. when asked whether TG would be sold eventually in may 2023, Mike referenced these 2 sales. My guess is that we GIA until Sq is out and indications for MG are approved maybe 2027 My plan is to keep my day job and wait it out
2 · Reply
Mr_Simpson
Mr_Simpson Jul. 17 at 12:35 AM
$TGTX Just close the week at $40 to $42.50 and anything is possible from that point forward. Market is booming...we are in the best 10 days of the year. Sell it Mike! ;)
0 · Reply
ModestMelody
ModestMelody Jul. 16 at 8:58 PM
$TGTX Just wanted to compare FB groups as a fun exercise. Briumvi 2.5K (+25 in last week) Kesimpta 12.5K (+30 in last week) Ocrevus 26.0K (+45 in last week) While I haven't seen the exponential growth that I was hoping to yet, it's nice to see us nearly matching Kesimpta's absolute growth rate (caveat that the other two have more than one group albeit the others have much fewer members).
1 · Reply
tracer2003
tracer2003 Jul. 16 at 8:55 PM
$TGTX Grok research for advertising push The increased frequency of TGTX’s TV commercials for BRIUMVI is consistent with pharmaceutical marketing to boost awareness or counter competition, though it’s likely a strategic push rather than a typical "new drug" launch, given the 2022 approval. A conservative estimate for a quarterly TV ad campaign (50 ads/week at $5,000 per ad) is $3.5–$4 million, including ~$250,000 in production costs for a 30-second ad (amortized over the campaign). A more aggressive campaign (100–200 ads/week) could cost $7$15 million, with production costs included. For precise figures, TGTX’s investor reports or ad tracking services would be needed. Let me know if you want deeper analysis!
1 · Reply
MJStock
MJStock Jul. 16 at 8:21 PM
$TGTX green is green. That 100% day will come.
0 · Reply
ern1in
ern1in Jul. 16 at 8:01 PM
$TGTX Yahoo Close > 38.83 ...... Not bad.
0 · Reply
ern1in
ern1in Jul. 16 at 7:58 PM
$TGTX 🧪
0 · Reply
Latest News on TGTX
TG Therapeutics: Estimates Could Soon Be Raised Again

May 28, 2025, 6:00 AM EDT - 7 weeks ago

TG Therapeutics: Estimates Could Soon Be Raised Again


TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:55 AM EDT - 2 months ago

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript


Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Mar 21, 2025, 11:50 AM EDT - 4 months ago

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher


TG Therapeutics: A Wonderful Hold

Mar 3, 2025, 3:59 PM EST - 4 months ago

TG Therapeutics: A Wonderful Hold


TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 11:55 AM EST - 4 months ago

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript


TG Therapeutics: 2025 Revenues Will Smash Expectations

Jan 21, 2025, 2:17 AM EST - 6 months ago

TG Therapeutics: 2025 Revenues Will Smash Expectations


TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 11:16 AM EST - 9 months ago

TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript


TG Therapeutics: Less Room For Doubt About Briumvi

May 3, 2024, 9:53 AM EDT - 1 year ago

TG Therapeutics: Less Room For Doubt About Briumvi


TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript

May 2, 2024, 10:21 PM EDT - 1 year ago

TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript


JinxyBio
JinxyBio Jul. 17 at 8:19 AM
$TGTX 2516
0 · Reply
Chartist0_0
Chartist0_0 Jul. 17 at 2:29 AM
$TGTX There's some really dumb ass people on this board. I've blocked and muted a lot of them and will continue to do so.
0 · Reply
Chartist0_0
Chartist0_0 Jul. 17 at 1:08 AM
$TGTX To value the business you can discount the future cash flows. This requires some estimation of what those cash flows will be. Go out to when the patent expires. Discount those flows to the present using some discount rate. I'd say 6% would work. I am surprised the company hasn't been bought out already. To me, this means MW wants too much, or it would be a done deal by now.
3 · Reply
Looey
Looey Jul. 17 at 12:51 AM
$TGTX Seagen was acquired by Pfizer for approximately $43 billion in a deal announced in March 2023 and completed in December 2023, at $229 per share in cash. Celgene was acquired by Bristol-Myers Squibb for approximately $74 billion in a cash and stock deal announced in January 2019 and completed in November 2019. when asked whether TG would be sold eventually in may 2023, Mike referenced these 2 sales. My guess is that we GIA until Sq is out and indications for MG are approved maybe 2027 My plan is to keep my day job and wait it out
2 · Reply
Mr_Simpson
Mr_Simpson Jul. 17 at 12:35 AM
$TGTX Just close the week at $40 to $42.50 and anything is possible from that point forward. Market is booming...we are in the best 10 days of the year. Sell it Mike! ;)
0 · Reply
ModestMelody
ModestMelody Jul. 16 at 8:58 PM
$TGTX Just wanted to compare FB groups as a fun exercise. Briumvi 2.5K (+25 in last week) Kesimpta 12.5K (+30 in last week) Ocrevus 26.0K (+45 in last week) While I haven't seen the exponential growth that I was hoping to yet, it's nice to see us nearly matching Kesimpta's absolute growth rate (caveat that the other two have more than one group albeit the others have much fewer members).
1 · Reply
tracer2003
tracer2003 Jul. 16 at 8:55 PM
$TGTX Grok research for advertising push The increased frequency of TGTX’s TV commercials for BRIUMVI is consistent with pharmaceutical marketing to boost awareness or counter competition, though it’s likely a strategic push rather than a typical "new drug" launch, given the 2022 approval. A conservative estimate for a quarterly TV ad campaign (50 ads/week at $5,000 per ad) is $3.5–$4 million, including ~$250,000 in production costs for a 30-second ad (amortized over the campaign). A more aggressive campaign (100–200 ads/week) could cost $7$15 million, with production costs included. For precise figures, TGTX’s investor reports or ad tracking services would be needed. Let me know if you want deeper analysis!
1 · Reply
MJStock
MJStock Jul. 16 at 8:21 PM
$TGTX green is green. That 100% day will come.
0 · Reply
ern1in
ern1in Jul. 16 at 8:01 PM
$TGTX Yahoo Close > 38.83 ...... Not bad.
0 · Reply
ern1in
ern1in Jul. 16 at 7:58 PM
$TGTX 🧪
0 · Reply
CreativeInvestments
CreativeInvestments Jul. 16 at 7:52 PM
$TGTX July 16, 2025 Thesis Grading a multi-year investment in TG Therapeutics (TGTX) https://fomo.transistor.fm/episodes/thesis-grading-a-multi-year-investment-in-tg-therapeutics-tgtx
0 · Reply
ians
ians Jul. 16 at 7:44 PM
$IOVA Start of runup to $10 consensus PT🤞 Reminds me of WS shenanigans post Briumvi approval for $TGTX. A fat cat bank cut its PT to $5 🤦‍♂️….well look at it now ☘️💎
0 · Reply
ngyojiw
ngyojiw Jul. 16 at 7:14 PM
$TGTX flat to end the day.
1 · Reply
ern1in
ern1in Jul. 16 at 7:09 PM
$TGTX @TroyTiger .....
0 · Reply
EverthingIbuyTANKS
EverthingIbuyTANKS Jul. 16 at 7:08 PM
$TGTX Dont turd now
0 · Reply
ngyojiw
ngyojiw Jul. 16 at 7:03 PM
$TGTX finish flat?
1 · Reply
TroyTiger
TroyTiger Jul. 16 at 6:52 PM
$TGTX $XBI looking good here.. $JNJ could surprise and make us an offer, IF they haven't already. They have the cash, $$. I have seen some accumulation the last few days with improving technicals.. this is definitely a strong BUY.
1 · Reply
ern1in
ern1in Jul. 16 at 6:29 PM
$TGTX / BRIUMVI / SUB-Q ..... POWER 🔋 UP !!!!!!
0 · Reply
CT_Biker
CT_Biker Jul. 16 at 6:13 PM
$TGTX With B poised to make 1B+ in 2026 , we are right where we should be. Expect the "BO JUMP TIMELINE" jump soon. Long or short, it will be fun!
3 · Reply
jeremytowe2000
jeremytowe2000 Jul. 16 at 6:08 PM
$TGTX Members · 2,512
2 · Reply
ern1in
ern1in Jul. 16 at 6:07 PM
$TGTX 🤔
0 · Reply
Maxwell_Smart
Maxwell_Smart Jul. 16 at 5:45 PM
0 · Reply